Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 13-3070077 · Snapshot of IRS recognition, filing currency, financial health, and governance.
2-2600-110213-00 oral carco cobalt chloride studyin 2024, preliminary activities for the study were initiated, including the development of a study plan with the test laboratory, establishing contracts with the test and analytical laboratories, identification of the test substance, and more. Initial test phases will begin in 2025 and lead up to the critical step of setting dose levels for the in-life portion of the study, which is anticipated to begin in q1 2026.
Total Revenue
$4.2M
FY2024
Total Expenses
$4.4M
FY2024
Net Assets
-$264K
Program Ratio
—
expenses on programs
Employees
—
Volunteers
—
Board Members
—
Voting
—
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.